CYCN stock forecast
Our latest prediction for Cyclerion Therapeutics Inc's stock price was made on the May 6, 2021 when the stock price was at 2.49$.
In the short term (2weeks), CYCN's stock price should outperform the market by 3.69%. During that period the price should oscillate between -10.98% and +23.40%.
In the medium term (3months), CYCN's stock price should outperform the market by 1.17%. During that period the price should oscillate between -43.69% and +62.34%.Get email alerts
Create a solid portfolio with CYCN
About Cyclerion Therapeutics Inc
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function. Cyclerion's lead program is CY6463, a novel, first-in-class, CNS-penetrant, sGC stimulator that modulates a key node in a fundamental CNS signaling network. The multidimensional pharmacology elicited by the stimulation of sGC has the potential to impact a broad range of CNS diseases. CY6463 has shown rapid improvement in biomarkers associated with cognitive impairment and is currently in clinical development for Alzheimer's Disease with Vascular pathology (ADv) and Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS).
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -2.22$ per share.
The book value per share is 5.15$
Three months stock forecastMay 6, 2021
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|